Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Annals of the Rheumatic Diseases 69.4 (2010). DOI:10.1136/ard.2009.123976
In: Annals of the Rheumatic Diseases 69 : 4 BMJ Publishing Group Ltd and European League Against Rheumatism, 2010-03-17 - S. 638-643
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2010
- Urheber
-
Schoels, Monika
Knevel, Rachel
Aletaha, Daniel
Bijlsma, Johannes W. J.
Breedveld, Ferdinand C.
Boumpas, Dimitrios T.
Burmester, Gerd
Combe, Bernard
Cutolo, Maurizio
dougados, maxime
Emery, Paul
van der Heijde, Desirée
Huizinga, Tom W. J.
Kalden, Joachim
Keystone, Edward C.
Kvien, Tore K.
Martin-Mola, Emilio
Montecucco, Carlomaurizio
de Wit, Maarten
Smolen, Josef S.
- DOI
-
10.1136/ard.2009.123976
- URN
-
urn:nbn:de:101:1-2411080432256.626518449582
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schoels, Monika
- Knevel, Rachel
- Aletaha, Daniel
- Bijlsma, Johannes W. J.
- Breedveld, Ferdinand C.
- Boumpas, Dimitrios T.
- Burmester, Gerd
- Combe, Bernard
- Cutolo, Maurizio
- dougados, maxime
- Emery, Paul
- van der Heijde, Desirée
- Huizinga, Tom W. J.
- Kalden, Joachim
- Keystone, Edward C.
- Kvien, Tore K.
- Martin-Mola, Emilio
- Montecucco, Carlomaurizio
- de Wit, Maarten
- Smolen, Josef S.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2010
Ähnliche Objekte (12)
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
New therapeutic targets in rheumatoid arthritis
Future therapeutic targets in rheumatoid arthritis?
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
PTEN: an emerging target in rheumatoid arthritis?
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
Rheumatoid arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis
Rheumatoid arthritis, [1]
Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
New therapeutic targets in rheumatoid arthritis
Future therapeutic targets in rheumatoid arthritis?
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
PTEN: an emerging target in rheumatoid arthritis?
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
Rheumatoid arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis
Rheumatoid arthritis, [1]
Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
New therapeutic targets in rheumatoid arthritis
Future therapeutic targets in rheumatoid arthritis?
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
PTEN: an emerging target in rheumatoid arthritis?
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
Rheumatoid arthritis
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis
Rheumatoid arthritis, [1]
Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis